[HTML][HTML] Complement component 7 is associated with total-and cardiac death in chest-pain patients with suspected acute coronary syndrome

R Aarsetøy, T Ueland, P Aukrust, AE Michelsen… - BMC Cardiovascular …, 2021 - Springer
Background Complement activation has been associated with atherosclerosis,
atherosclerotic plaque destabilization and increased risk of cardiovascular events …

Serum complement C3/C4 ratio, a novel marker for recurrent cardiovascular events

A Palikhe, J Sinisalo, M Seppänen, H Haario… - The American journal of …, 2007 - Elsevier
Acute coronary syndrome is an inflammatory disease, during which the complement
cascade is activated. We assessed the complement C3 and C4 concentration ratio (C3/C4 …

[HTML][HTML] Association of serum complement C1q with cardiovascular outcomes among patients with acute coronary syndrome undergoing percutaneous coronary …

LI Qiu-Xuan, MA Xiao-Teng, S Qiao-Yu… - Journal of Geriatric …, 2022 - ncbi.nlm.nih.gov
OBJECTIVE To determine the association of serum complement C1q levels with
cardiovascular outcomes among patients with acute coronary syndrome (ACS) undergoing …

Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis

WS Speidl, M Exner, J Amighi, SP Kastl… - European heart …, 2005 - academic.oup.com
Aims Complement activation occurs in atherosclerotic lesions, and particularly complement
component C5a exerts potent chemotactic and proinflammatory effects. However, it is yet …

[HTML][HTML] Chemokine ligand 18 predicts all-cause mortality in patients hospitalized with chest pain of suspected coronary origin

DWT Nilsen, R Aarsetoey, V Poenitz, T Ueland… - International Journal of …, 2024 - Elsevier
Introduction Chemokines mediate recruitment and activation of leucocytes. Chemokine
ligand 18 (CCL18) is mainly expressed by monocytes/macrophages and dendritic cells. It is …

Elevated C1rC1sC1inh levels independently predict atherosclerotic coronary heart disease

Z Horváth, D Csuka, K Vargova, A Kovács… - Molecular …, 2013 - Elsevier
Clinical studies as well as animal models emphasized the importance of the complement
system in the pathogenesis of coronary atherosclerosis and cardiovascular diseases. Our …

[HTML][HTML] CC chemokine ligands in patients presenting with stable chest pain: association with atherosclerosis and future cardiovascular events

MO Versteylen, M Manca, IA Joosen… - Netherlands Heart …, 2016 - Springer
Background CC chemokine ligands (CCLs) are elevated during acute coronary syndrome
(ACS) and correlate with secondary events. Their involvement in plaque inflammation led us …

Complement C3 and C-reactive protein levels in patients with stable coronary artery disease

R Ajjan, PJ Grant, TS Futers, JM Brown… - Thrombosis and …, 2005 - thieme-connect.com
The aim of this study was to determine whether complement C3 is an indicator of coronary
artery disease (CAD). We measured plasma C3 and CRP levels in 278 patients undergoing …

Complement activation products C5a and sC5b-9 are associated with low-grade inflammation and endothelial dysfunction, but not with atherosclerosis in a cross …

E Hertle… - International …, 2014 - internationaljournalofcardiology.com
Low-grade inflammation is involved in endothelial dysfunction, atherosclerosis and
cardiovascular disease (CVD)[1]. The complement system is an ancient inducer of …

Complement activation in acute myocardial infarction: An early marker of inflammation and tissue injury?

L Bavia, KCF Lidani, FA Andrade, MIAH Sobrinho… - Immunology …, 2018 - Elsevier
Background Acute myocardial infarction (AMI) is a potentially fatal condition, being a major
cause of death worldwide. Ischemia suffered during AMI causes tissue damage, leading to …